Core Insights - Altria Group, Inc. is facing significant challenges as it transitions towards smoke-free alternatives, primarily due to the rise of illicit flavored disposable e-vapor products that are reshaping the U.S. nicotine market [1][3]. Company Performance - In Q1 2025, Altria reported that the adult e-vapor user base in the U.S. has exceeded 20 million, with a year-over-year increase of over 2.6 million users, largely driven by disposable e-vapor products which gained nearly 4 million new users, reaching around 14 million [2]. - Altria estimates that over 60% of the expanding e-vapor market is now dominated by unauthorized, non-compliant products, which poses a significant challenge to its smoke-free revenue growth [2][10]. Market Dynamics - The surge in illicit e-vapor products is a major obstacle for Altria's smoke-free revenue growth, dampening its progress despite an increasing market presence [3]. - The company is collaborating with regulators to address enforcement gaps, but the ongoing availability of illicit products remains a significant barrier [4]. Competitive Landscape - Major tobacco companies like Philip Morris International and British American Tobacco are also accelerating their transition towards smoke-free alternatives, investing in reduced-risk products to adapt to changing consumer preferences and regulatory landscapes [6]. - Philip Morris reported that smoke-free offerings contributed 44% of its gross profit in Q1 2025, with a 20.4% rise in net revenues and a 33.1% increase in smoke-free gross profit [7]. - British American Tobacco aims to reach 50 million consumers by 2030, with its smokeless user base reaching 29.1 million in 2024 [8]. Financial Metrics - Altria's shares have gained 14.4% year-to-date, compared to the industry's growth of 40.8% [9]. - The company trades at a forward price-to-earnings ratio of 10.96X, below the industry average of 15.74X, with a forecasted EPS growth of 5.3% for 2025 [10][12]. - The Zacks Consensus Estimate for Altria's 2025 earnings implies a year-over-year growth of 5.3%, while the 2026 earnings estimate suggests an increase of almost 3% [13].

Group 1 - The focus is on growth and dividend income as a strategy for retirement planning [1] - The portfolio is structured to generate monthly dividend income that grows through reinvestment and annual increases [1] Group 2 - The article expresses personal opinions and is not intended as investment advice [2][3] - It emphasizes the importance of conducting individual research before making investment decisions [2]

Core Insights - Altria Group, Inc. is experiencing significant challenges in its smokeable products segment, with a notable decline in cigarette volumes and revenues [1][8] - The overall tobacco industry is facing economic pressures, leading to a shift towards discount brands and an increase in illicit e-vapor products [2][3] Company Performance - In Q1 2025, Altria's domestic cigarette shipment volumes decreased by 13.7%, while net revenues from the smokeable segment fell by 5.8% year over year to $4.62 billion [1][8] - The company's total revenues dropped by 5.7% in the same quarter, reflecting the impact of economic strain on consumers [2] Market Dynamics - Inflation and stagnant wage growth are pushing low-income smokers towards cheaper alternatives, resulting in a 1.8 share point gain for the discount cigarette segment [2] - Altria's flagship Marlboro brand experienced a 1-point decline in retail share year over year [2] Competitive Landscape - The illegal disposable e-vapor market is estimated to dominate over 60% of the e-vapor market, further impacting traditional cigarette demand [3] - Competitors like Philip Morris International and British American Tobacco are also facing structural pressures in their combustible segments, with both companies pivoting towards reduced-risk products (RRPs) [5][6] Strategic Response - Altria may need to accelerate its transition to smoke-free alternatives to sustain growth and investor confidence, as evidenced by its investments in platforms like NJOY and on! [4] - The company’s current valuation shows a forward price-to-earnings ratio of 10.73X, below the industry average of 15.47X, indicating potential undervaluation [10] Earnings Estimates - The Zacks Consensus Estimate for Altria's 2025 earnings implies a year-over-year growth of 5.3%, with a 3% uptick expected in 2026 [12]

Core Viewpoint - Altria Group is gaining attention from institutional investors despite its association with tobacco products, as it offers stability and high dividend yields in a volatile market [2][3][15]. Group 1: Institutional Interest - A major institutional player acquired $1.3 billion worth of Altria Group shares, indicating significant interest from large investors [4]. - The stock is trading within 5% of a new 52-week high, suggesting bullish momentum and investor confidence [6]. Group 2: Financial Performance - Altria Group has a gross profit margin of 70.8%, showcasing its pricing power and market share [8][9]. - The company maintains a net income margin of 50.4%, allowing for efficient capital allocation [10]. - Altria generates an average return on invested capital (ROIC) of 40% annually, enabling reinvestment in growth and shareholder benefits [11]. Group 3: Dividend and Income Potential - The company offers a dividend yield of 6.9%, with an annual dividend payment of $4.08 per share, appealing to income-focused investors [13][14]. - Altria has a strong track record of dividend increases over 56 years, reinforcing its reliability as an income-generating asset [14][15].

Core Viewpoint - Altria Group, the largest cigarette maker in North America, is facing significant challenges due to declining cigarette volumes, despite rising earnings and dividends, raising concerns for investors [1][9]. Company Overview - Altria primarily focuses on cigarette production, with 14.2 billion cigarettes produced in Q1 2025, accounting for approximately 97% of its smokable products [3]. - Smokable products contribute around 88% to Altria's revenue, highlighting the importance of cigarettes to its business model [3]. Industry Trends - Cigarette volumes are declining, with a 13.7% decrease in production from nearly 16.5 billion in Q1 2024 to 14.2 billion in Q1 2025 [4]. - Historical data shows a significant drop from over 25 billion cigarettes produced in Q1 2020, indicating ongoing industry headwinds [4]. Company Strategies - Altria has attempted to mitigate the impact of declining cigarette demand through price increases, leveraging the addictive nature of nicotine to maintain some pricing power [5]. - However, recent trends suggest that price increases alone are insufficient to sustain revenue growth [6]. Financial Performance - Despite a year-over-year revenue decline of 5.7% in Q1 2025, generating approximately $5.3 billion compared to nearly $6.4 billion in 2020, Altria has managed to keep earnings and dividends rising [9]. - The company has reduced its share count from 1.758 billion in Q1 2024 to 1.69 billion in Q1 2025, primarily through stock buybacks, which has helped support earnings [7][10]. Future Outlook - While Altria currently offers a 6.7% dividend yield, the company must find alternatives to cigarettes to avoid a potential terminal decline [11].

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style Sc ...

Key Takeaways on! pouch shipments rose 18% in Q1 2025, hitting over 39 million cans and gaining market traction. on! gained 1.8 share points in oral tobacco and 0.5 in nicotine pouches in Q1, signaling growing demand. Oral Tobacco revenues rose to $654M, up 0.5% year over year in Q1, driven by strong pricing execution.Altria Group, Inc. (MO) is making steady progress toward a smoke-free future, with its oral nicotine pouch brand on! emerging as a key growth driver. As consumer preferences shift toward red ...

Core Viewpoint - Altria has demonstrated solid price appreciation over the past year, with an increase of 27% [1] Company Summary - Altria is recognized as a strong dividend-paying company, appealing to dividend investors [1]

Core Viewpoint - The tobacco industry is evolving into the nicotine industry, with Altria Group and British American Tobacco being key players, but British American Tobacco is currently better positioned for growth and market share in smokeless products [2][10][12]. Company Comparison - Altria and British American Tobacco both offer high dividend yields around 7% and have similar financial metrics, but their growth prospects differ significantly [2][5]. - Altria primarily operates in the U.S. with its Marlboro brand, while British American Tobacco has a global presence and competes mainly with Philip Morris International [4]. Financial Health - Both companies generate sufficient free cash flow to cover dividends and have significant stakes in other companies, with Altria's stake in Anheuser-Busch InBev valued at approximately $11 billion and British American Tobacco's stake in ITC Limited valued at around $16 billion [7]. Industry Adaptation - The decline in traditional cigarette use has prompted both companies to invest in smokeless nicotine products, with British American Tobacco leading in the electronic vape market with a 40% market share and 13.2% of total revenue from new product categories in 2024 [9][10]. - Altria has struggled with its investments in smokeless products, reporting only $300 million in sales from new categories in 2024, which is just 1.2% of its total revenue [11]. Market Dynamics - The U.S. government’s crackdown on illegal vape products benefits both companies, but British American Tobacco is expected to gain more due to its strong market share in vaping [14]. - Altria faces challenges in maintaining its market leadership in next-generation nicotine products, which could weaken its business as cigarette volumes decline [15].

Core Viewpoint - Altria's stock has seen a slight increase of approximately 0.6% since its last earnings report, underperforming compared to the S&P 500, raising questions about its future performance leading up to the next earnings release [1] Estimates Movement - Estimates for Altria have trended upward over the past month, indicating a positive outlook for the stock [2] VGM Scores - Altria has a Growth Score of B, a Momentum Score of D, and a Value Score of B, placing it in the top 40% for the value investment strategy. The overall aggregate VGM Score for the stock is A, which is significant for investors not focused on a single strategy [3] Outlook - The upward trend in estimates suggests a promising outlook for Altria, which currently holds a Zacks Rank of 3 (Hold). The expectation is for an in-line return from the stock in the upcoming months [4] Industry Performance - Altria is part of the Zacks Tobacco industry, where another player, Philip Morris, has experienced a gain of 4.3% over the past month. Philip Morris reported revenues of $9.3 billion for the last quarter, reflecting a year-over-year increase of 5.8% [5] Philip Morris Earnings Expectations - For the current quarter, Philip Morris is projected to report earnings of $1.84 per share, representing a year-over-year change of 15.7%. The Zacks Consensus Estimate for Philip Morris has remained unchanged over the last 30 days, and it holds a Zacks Rank of 1 (Strong Buy) [6]